Our researchers work across the full range of biomedical and clinical sciences, from the molecule to large population studies. The excellence of our research is recognised by our top placing in international league tables and top ranking for overall quality in the Research Excellence Framework.
15 April 2021
COVID-19 leads to a several-times higher risk of cerebral venous thrombosis (CVT) blood clots than current COVID-19 vaccines.
12 April 2021
Inhaled budesonide, a common corticosteroid, is the first widely available, inexpensive drug found to shorten recovery times in COVID-19 patients aged over 50 who are treated at home and in other community settings, reports the PRINCIPLE trial in 1,779 participants.
7 April 2021
One in three COVID-19 survivors received a neurological or psychiatric diagnosis within six months of infection with the SARS-CoV-2 virus, an observational study of more than 230,000 patient health records published in The Lancet Psychiatry journal estimates. The study looked at 14 neurological and mental health disorders.
Pictures courtesy of: Nasir Hamid, OU Images and Shutterstock